May 14, 2020 / 1:19 PM / 16 days ago

BRIEF-Sierra Oncology To Report Data On Momelotinib At European Hematology Association Congress

May 14 (Reuters) - Sierra Oncology Inc:

* SIERRA ONCOLOGY TO REPORT FAVORABLE DOSE INTENSITY DATA AND LONG-TERM SAFETY DATA FOR MOMELOTINIB AT THE 25TH EUROPEAN HEMATOLOGY ASSOCIATION (EHA) CONGRESS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below